Convertible Loan Agreement Singapore | Companies Act 1967

A convertible loan is debt. The investor lends the company a sum, the loan accrues interest and carries a maturity date, and instead of being repaid in cash it converts into shares when a qualifying financing round closes. If that round never happens, the debt sits on the balance sheet and, in principle, becomes repayable at maturity, which gives the investor real leverage. A SAFE, by contrast, is not a loan at all: it carries no interest and no maturity date, and it simply converts into equity when the trigger event occurs. The trade-off is straightforward. The note holder keeps a repayment claim as a fallback; the SAFE holder gives that up in exchange for lighter, faster paper.

Singapore founders have a third option that most global templates ignore. The CARE (Convertible Agreement Regarding Equity) is the local-law equivalent of the American SAFE, published in the VIMA model document suite by the Singapore Academy of Law and the Singapore Venture Capital and Private Equity Association. It does the same job as a SAFE but is drafted under Singapore law, so the governing-law and dispute-resolution conversation with a local investor disappears. Whichever form you choose, the economic heart is identical: money now, shares later, priced by a valuation cap or a discount to the next round. This template covers both the interest-bearing convertible note and the equity-style SAFE or CARE structure, so you can pick the instrument that matches your investor.

Three statutes govern how these instruments behave in Singapore, and getting the interaction right is what separates a clean raise from a regulatory problem. The first is the Companies Act 1967. Conversion is not automatic in the company-law sense; it is an allotment of new shares, and section 161 requires directors to hold prior shareholder authority before they allot. Founders typically pass a general mandate authorising the directors to issue shares, including on the conversion of convertibles, then lodge a Return of Allotment with ACRA within 14 days of the actual issuance. Skip the section 161 authority and the allotment is void, so the instrument should record the mandate the board is relying on and the company should keep it refreshed.

The second is the Securities and Futures Act 2001. An offer of securities, and a convertible instrument that will become shares is an offer of securities, normally requires a registered prospectus under section 240. Early-stage startups almost always rely on an exemption instead. The small offers exemption caps the total raised at S$5 million in any 12-month period, while the private placement exemption under section 272B limits the offer to no more than 50 persons over 12 months; offers made only to accredited or institutional investors are exempt separately. The stakes here are not theoretical. In Public Prosecutor v Tay Chee Ming [2020] SGMC 1, a director who raised roughly S$8 million from the public through convertible loan agreements was convicted under section 240 and jailed for 15 months, because the personal-offer conditions of the exemption were not met. The Monetary Authority of Singapore sets out the exempted-offer conditions in its guidance on the offers of securities regulated under the SFA, which is worth reading before you send the paper to anyone outside your close network.

The third is the Moneylenders Act 2008, which matters only for the note. Lending money for repayment of a larger sum presumptively makes the lender a moneylender, but a person who lends solely to corporations is an excluded moneylender and falls outside the licensing regime. The instrument should therefore make clear the loan is advanced to the company, not jointly to the company and its founders. The Electronic Transactions Act 2010 completes the picture, giving electronic signatures full validity for a document of this kind, so the whole thing can be signed and closed remotely.

The classic trigger is the pre-seed or bridge raise, when a startup needs capital to reach the milestones that justify a priced round but neither side wants to negotiate a valuation yet. A convertible defers that fight to the Series A, when there is real data to price against. Founders reach for it again when a friendly angel or an early customer offers to put in money quickly and a full equity round would be disproportionate to the cheque size. The instrument slots neatly into the funding journey: after the founders' own capital and any grant money, and before the first priced seed or Series A.

Bridge financing between rounds is the second common scenario. A company that has raised a seed round but is a few months short of its Series A can take a top-up from existing investors on a convertible, converting alongside the incoming money at an agreed discount. A related edge case worth flagging is the down-round bridge, where the company's prospects have dipped: here the valuation cap does most of the work, and founders should model how much dilution a low cap will cause if the next round prices below expectations. Corporate or strategic investors sometimes prefer a note over a SAFE because the maturity date preserves a repayment claim, which their internal mandate may require. The one situation to avoid entirely is a broad solicitation of the public, because that is precisely what pushes the raise outside the SFA exemptions and into prospectus territory, as the Tay Chee Ming prosecution shows. When your cap table and reserved matters start to get complex, it is usually the point to graduate from convertibles to a full Singapore shareholders' agreement.

• The conversion trigger and mechanics define the qualifying financing event, the valuation cap and the discount rate, and set out the arithmetic that turns the invested amount into a share count. This is the commercial core of the instrument, and the template drafts it so the investor receives the more favourable of the cap price and the discount price, the market-standard outcome that local investors expect.
• The maturity and interest terms apply to the convertible note version. The template records the interest rate, whether it accrues to the principal or is paid, and what happens at maturity if no qualifying round has closed, whether the loan converts at a default valuation, extends, or becomes repayable. The SAFE and CARE version simply omits these, since neither carries interest or a maturity date.
• The liquidity and dissolution provisions protect the investor if the company is sold or wound up before conversion. On a trade sale the investor takes the higher of their money back or the converted value; on a winding up their subscription amount ranks ahead of the ordinary shares. These safety valves are standard in the VIMA CARE and are built into the template.
• The section 161 authority and allotment machinery ties the instrument to Singapore company law. It references the shareholder mandate the directors rely on to allot conversion shares and flags the ACRA Return of Allotment lodgement, so the paperwork on conversion day is already mapped. A Singapore directors' and shareholders' resolution pairs naturally with this to record the approvals.
• The prospectus-exemption representations record which SFA safe harbour the raise relies on, whether the small offers cap, the private placement limit, or the accredited-investor route, and bind the investor to resale restrictions where they apply. This is the clause that keeps the raise on the right side of section 240.

Singapore is a single unified jurisdiction, so there are no state or provincial variations to layer in, but the shape of your raise changes materially with the type of investor you approach, and that is where the real drafting decisions sit. An offer made solely to accredited investors, broadly individuals with net personal assets above S$2 million or net financial assets above S$1 million, or to institutional investors, sits within its own SFA exemption and gives you the widest runway. You still respect section 161 and lodge the allotment, but the 50-person and S$5 million ceilings of the small offers and private placement routes fall away. Most seed-stage founders raising from angels and micro-VCs live in exactly this space.

Founders raising from a broader circle of friends, customers or business contacts must instead thread the private placement needle: no more than 50 offerees in any 12-month period, no advertising, and a resale lock of six months on the securities. The critical trap, laid bare in Public Prosecutor v Tay Chee Ming, is that the small offers exemption requires a genuine personal offer, meaning the offeree must have a prior connection to the company or a prior indication of interest. Cold approaches to strangers, even below the dollar cap, do not qualify. If your convertible is structured as a note, keep the lending confined to the company itself to preserve excluded moneylender status under the Moneylenders Act 2008. And whichever exemption you rely on, remember that offers can be aggregated where they are closely related, so a series of small tranches to overlapping investors may be counted together against the ceilings. When the company is ready to formalise ownership after conversion, the Singapore Pte Ltd company constitution and the instrument of share transfer become the next documents in the sequence.

You start by choosing the instrument that fits your investor: an interest-bearing convertible note if they want a repayment fallback, or a SAFE or CARE-style agreement if both sides prefer clean equity paper with no maturity. From there the template asks for the company's details, the investor's details and the invested amount, then walks you through the commercial terms that do the pricing. You set the valuation cap, the discount rate and the definition of the qualifying financing round that triggers conversion, and, for a note, the interest rate and maturity date. The template then adjusts the liquidity and dissolution language to match the instrument you picked. Next you confirm which SFA exemption the raise relies on, which slots the correct representations and resale restrictions into the agreement, and you note the section 161 authority the directors will use to allot the conversion shares. Because the Electronic Transactions Act 2010 makes electronic signature valid here, both parties can sign the finished document remotely and the company can move straight to keeping the executed copy with its records ready for conversion day.

The most damaging error is treating conversion as automatic. It is not; it is an allotment of shares that needs section 161 authority in place first, and founders who convert without a valid mandate can find the issuance void, which unravels the whole cap table at the worst possible moment. A close second is misjudging the SFA exemption. Founders routinely assume that a small raise is automatically exempt, but the Tay Chee Ming case shows that raising even modest sums from people with no genuine prior connection to the company breaches the personal-offer requirement and exposes the director to prosecution under section 240. Advertising the round, or letting it drift past 50 offerees, does the same damage.

On the commercial side, the recurring miss is a valuation cap set without modelling the dilution. A low cap looks investor-friendly on signing but can hand away far more equity than founders expect if the company grows quickly before the priced round. Leaving the note-versus-SAFE choice vague is another trap, because an interest rate and a maturity date carry consequences a SAFE simply does not, and mixing the two produces an instrument neither side fully understands. Finally, founders forget the downstream paperwork: the ACRA Return of Allotment within 14 days of conversion, the update to the register of members, and consistency with the Singapore founders' agreement already in place. Skipping these turns a clean raise into a compliance clean-up later.